286 Cardinal Medeiros AvenueCambridge, MA 02141
President & CEO
Seventh Sense Biosystems, Inc.
Seventh Sense Biosystems is developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. The company's initial focus is on improving important diagnostic testing at the point of care by reducing the discomfort, anxiety and hassle of blood sample collection.
Harry Wilcox is on the Board of Directors.